Celularity Inc (CELU) earnings · rev $26.6M
Celularity Inc (CELU) is a biotechnology company listed on US.
This CELU earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CELU revenue for 2025-12-31 was $26.6M. Net income was -$91.7M. Revenue was down 51.0% from 2024-12-31 to 2025-12-31. CELU currently screens at market cap $25.2M.
When the next CELU 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 51.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full CELU research stays on the stock page; the tape stays on the quote page.
Not investment advice.